Clinical and Immunological Outcomes in High-Risk Resected Melanoma Patients Receiving Peptide-Based Vaccination and Interferon Alpha, With or Without Dacarbazine Preconditioning: A Phase II Study

Clinical studies based on novel rationales and mechanisms of action of chemotherapy agents and cytokines can contribute to the development of new concepts and strategies of antitumor combination therapies. In previous studies, we investigated the paradoxical immunostimulating effects of some chemoth...

Descripción completa

Detalles Bibliográficos
Autores principales: Urbani, Francesca, Ferraresi, Virginia, Capone, Imerio, Macchia, Iole, Palermo, Belinda, Nuzzo, Carmen, Torsello, Angela, Pezzotti, Patrizio, Giannarelli, Diana, Pozzi, Anna Fausta, Santaquilani, Mariano, Roazzi, Paolo, Bastucci, Silvia, Catricalà, Caterina, La Malfa, Antonia, Vercillo, Giuseppe, Gualtieri, Novella, Buccione, Carla, Castiello, Luciano, Cognetti, Francesco, Nisticò, Paola, Belardelli, Filippo, Moschella, Federica, Proietti, Enrico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7069350/
https://www.ncbi.nlm.nih.gov/pubmed/32211314
http://dx.doi.org/10.3389/fonc.2020.00202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7069350/
https://www.ncbi.nlm.nih.gov/pubmed/32211314
http://dx.doi.org/10.3389/fonc.2020.00202

Ejemplares similares